Peloton Seen Benefiting from Increased Focus on Fitness, Rise of GLP-1s -- Market Talk

Dow Jones03-25 00:40

1239 ET - Peloton Interactive has a number of structural tailwinds as the fitness industry continues to grow, UBS analysts say in a note. Younger generations are allocating more of their spending on health and wellness, and the rise of GLP-1 drugs is also playing a factor, the analysts say. As the drugs become more affordable and more people use them, they have to urgently incorporate cardio and strength exercises in their daily routines to prevent loss of muscle mass and bone density, the analysts say. Such shifts align well with Peloton's business, given it sells workout equipment and facilitates streaming access to fitness classes. The fitness industry will likely continue to capitalize on consumers' behavioral shifts to prioritize health, the analysts say. (kelly.cloonan@wsj.com)

(END) Dow Jones Newswires

March 24, 2026 12:40 ET (16:40 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment